Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Farrell

Showing results (51-60 of 522) with videos related to

Pageof 53
Sort By:
Addiction (Abingdon, England)|February 10, 2018
Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real worldSuzanne Nielsen, Sarah Larney, Michael Farrell
Addiction (Abingdon, England)|January 5, 2024
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?Wayne Hall, Shane Darke, Michael Farrell
Mitochondrion|May 14, 2017
Mitochondrial dysfunction in ocular disease: Focus on glaucomaKhalid Kamel, Michael Farrell, Colm O'Brien
Drug and Alcohol Review|March 8, 2014
Compulsory treatment of addiction in the patient's best interests: more rigorous evaluations are essentialWayne Hall, Michael Farrell, Adrian Carter
Addiction (Abingdon, England)|August 13, 2016
Yes, people can die from opiate withdrawalShane Darke, Sarah Larney, Michael Farrell
The Lancet. Neurology|March 22, 2005
Progressive myoclonic epilepsies: a review of genetic and therapeutic aspectsAmre Shahwan, Michael Farrell, Norman Delanty
Journal of Clinical Ultrasound : JCU|November 5, 2003
Testicular hamartomas in Cowden diseaseChristopher Lindsay, Lisa Boardman, Michael Farrell
The Journal of the American Academy of Psychiatry and the Law|July 18, 2006
PTSD in railroad drivers under the Federal employers' liability actKenneth J Weiss, J Michael Farrell
Human Movement Science|July 5, 2011
The effect of dividing attention between walking and auxiliary tasks in people with Parkinson's diseasePamela Fok, Michael Farrell, Joan McMeeken
Journal of Neurosciences in Rural Practice|April 20, 2019
Spinal Cord Ependymoma - Surgical Management and OutcomeWail Mohammed, Michael Farrell, Ciaran Bolger
Pageof 53

Showing results (51-60 of 522) with videos related to

Sort By:
Pageof 53
Addiction (Abingdon, England)|February 10, 2018
Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real worldSuzanne Nielsen, Sarah Larney, Michael Farrell
Addiction (Abingdon, England)|January 5, 2024
Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?Wayne Hall, Shane Darke, Michael Farrell
Mitochondrion|May 14, 2017
Mitochondrial dysfunction in ocular disease: Focus on glaucomaKhalid Kamel, Michael Farrell, Colm O'Brien
Drug and Alcohol Review|March 8, 2014
Compulsory treatment of addiction in the patient's best interests: more rigorous evaluations are essentialWayne Hall, Michael Farrell, Adrian Carter
Addiction (Abingdon, England)|August 13, 2016
Yes, people can die from opiate withdrawalShane Darke, Sarah Larney, Michael Farrell
The Lancet. Neurology|March 22, 2005
Progressive myoclonic epilepsies: a review of genetic and therapeutic aspectsAmre Shahwan, Michael Farrell, Norman Delanty
Journal of Clinical Ultrasound : JCU|November 5, 2003
Testicular hamartomas in Cowden diseaseChristopher Lindsay, Lisa Boardman, Michael Farrell
The Journal of the American Academy of Psychiatry and the Law|July 18, 2006
PTSD in railroad drivers under the Federal employers' liability actKenneth J Weiss, J Michael Farrell
Human Movement Science|July 5, 2011
The effect of dividing attention between walking and auxiliary tasks in people with Parkinson's diseasePamela Fok, Michael Farrell, Joan McMeeken
Journal of Neurosciences in Rural Practice|April 20, 2019
Spinal Cord Ependymoma - Surgical Management and OutcomeWail Mohammed, Michael Farrell, Ciaran Bolger
Pageof 53